- Home
- ANGO vs SENS Comparison
ANGO vs SENS Comparison
Compare ANGO & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANGO
- SENS
- Stock Information
- Founded
- ANGO 1988
- SENS 1996
- Country
- ANGO United States
- SENS United States
- Employees
- ANGO N/A
- SENS N/A
- Industry
- ANGO Medical/Dental Instruments
- SENS Industrial Machinery/Components
- Sector
- ANGO Health Care
- SENS Industrials
- Exchange
- ANGO Nasdaq
- SENS Nasdaq
- Market Cap
- ANGO 406.9M
- SENS 396.0M
- IPO Year
- ANGO 2004
- SENS N/A
- Fundamental
- Price
- ANGO $9.78
- SENS $0.47
- Analyst Decision
- ANGO Strong Buy
- SENS Strong Buy
- Analyst Count
- ANGO 2
- SENS 3
- Target Price
- ANGO $14.00
- SENS $1.70
- AVG Volume (30 Days)
- ANGO 712.9K
- SENS 6.3M
- Earning Date
- ANGO 07-15-2025
- SENS 08-07-2025
- Dividend Yield
- ANGO N/A
- SENS N/A
- EPS Growth
- ANGO N/A
- SENS N/A
- EPS
- ANGO N/A
- SENS N/A
- Revenue
- ANGO $283,320,000.00
- SENS $23,682,000.00
- Revenue This Year
- ANGO N/A
- SENS $60.14
- Revenue Next Year
- ANGO $6.35
- SENS $36.55
- P/E Ratio
- ANGO N/A
- SENS N/A
- Revenue Growth
- ANGO N/A
- SENS 1.64
- 52 Week Low
- ANGO $5.47
- SENS $0.25
- 52 Week High
- ANGO $13.50
- SENS $1.40
- Technical
- Relative Strength Index (RSI)
- ANGO 42.59
- SENS 37.42
- Support Level
- ANGO $9.75
- SENS $0.49
- Resistance Level
- ANGO $10.24
- SENS $0.51
- Average True Range (ATR)
- ANGO 0.42
- SENS 0.02
- MACD
- ANGO -0.14
- SENS 0.00
- Stochastic Oscillator
- ANGO 6.21
- SENS 6.23
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.
About SENS Senseonics Holdings Inc.
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.